Platelet factor 4 is chemotactic for neutrophils and monocytes.

PubWeight™: 3.03‹?› | Rank: Top 1%

🔗 View Article (PMC 319837)

Published in Proc Natl Acad Sci U S A on July 01, 1981

Authors

T F Deuel, R M Senior, D Chang, G L Griffin, R L Heinrikson, E T Kaiser

Articles citing this

Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci U S A (1987) 6.90

Identification and characterization of macrophage inflammatory protein 2. Proc Natl Acad Sci U S A (1989) 3.88

Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest (1982) 3.77

A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity. J Exp Med (1988) 2.90

A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines. Proc Natl Acad Sci U S A (1990) 2.50

Genomic characterization of a gamma-interferon-inducible gene (IP-10) and identification of an interferon-inducible hypersensitive site. Mol Cell Biol (1987) 2.41

Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci U S A (1995) 2.37

Chemotactic activity of platelet alpha granule proteins for fibroblasts. J Cell Biol (1983) 2.28

Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. Proc Natl Acad Sci U S A (1993) 2.09

Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils. J Exp Med (1989) 1.98

Chemokines and tissue injury. Am J Pathol (1995) 1.90

Constitutive expression of a gene encoding a polypeptide homologous to biologically active human platelet protein in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci U S A (1987) 1.90

Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. J Clin Invest (1985) 1.79

Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J Clin Invest (1986) 1.72

Human arterial wall cells secrete factors that are chemotactic for monocytes. Proc Natl Acad Sci U S A (1983) 1.64

Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol (2008) 1.51

Endothelial cell "memory" of inflammatory stimulation: human venular endothelial cells store interleukin 8 in Weibel-Palade bodies. J Exp Med (1998) 1.40

Modulation of JE/MCP-1 expression in dermal wound repair. Am J Pathol (1995) 1.33

Interferon-inducible gene maps to a chromosomal band associated with a (4;11) translocation in acute leukemia cells. Proc Natl Acad Sci U S A (1987) 1.33

Structure of the rat platelet factor 4 gene: a marker for megakaryocyte differentiation. Mol Cell Biol (1987) 1.29

Transcriptional regulation of the rat platelet factor 4 gene: interaction between an enhancer/silencer domain and the GATA site. Mol Cell Biol (1991) 1.28

Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin Immunopathol (2011) 1.26

Selective targeting of gene products with the megakaryocyte platelet factor 4 promoter. Proc Natl Acad Sci U S A (1991) 1.24

Platelets mediate neutrophil-dependent immune complex nephritis in the rat. J Clin Invest (1988) 1.20

Platelet-derived collagenase inhibitor: characterization and subcellular localization. Proc Natl Acad Sci U S A (1985) 1.15

Identification and characterization of PF4varl, a human gene variant of platelet factor 4. Mol Cell Biol (1989) 1.15

The inhibitory complex of human alpha 1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant. J Exp Med (1988) 1.08

Evidence of a role for mesothelial cell-derived interleukin 8 in the pathogenesis of asbestos-induced pleurisy in rabbits. J Clin Invest (1992) 1.07

New synthesis of a platelet-specific protein: platelet factor 4 synthesis in a megakaryocyte-enriched rabbit bone marrow culture system. J Cell Biol (1983) 1.06

Protease-induced immunoregulatory activity of platelet factor 4. Proc Natl Acad Sci U S A (1986) 1.05

Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting. Cancer Ther (2009) 1.03

Stimulation of histamine release from human basophils by human platelet factor 4. J Clin Invest (1983) 1.02

Platelet dysfunction: a new dimension in inflammatory bowel disease. Gut (1995) 1.01

Mediators of neutrophil recruitment in human abdominal aortic aneurysms. Cardiovasc Res (2009) 1.01

Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding. Biochem J (1995) 1.00

Touch of chemokines. Front Immunol (2012) 1.00

Activation of human peripheral blood monocytes by lipoproteins. Am J Pathol (1988) 0.96

Dissociation of the chemotactic and mitogenic activities of platelet-derived growth factor by human neutrophil elastase. J Cell Biol (1985) 0.95

The serpin-enzyme complex (SEC) receptor mediates the neutrophil chemotactic effect of alpha-1 antitrypsin-elastase complexes and amyloid-beta peptide. J Clin Invest (1992) 0.95

Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc Natl Acad Sci U S A (1983) 0.94

Slit2 prevents neutrophil recruitment and renal ischemia-reperfusion injury. J Am Soc Nephrol (2013) 0.91

Transformation-associated cytokine 9E3/CEF4 is chemotactic for chicken peripheral blood mononuclear cells. J Virol (1993) 0.86

Immunoregulatory activity of peptides related to platelet factor 4. Proc Natl Acad Sci U S A (1989) 0.85

Phagocytosis by Thrombocytes is a Conserved Innate Immune Mechanism in Lower Vertebrates. Front Immunol (2014) 0.84

Glomerular mesangial cell migration. Response to platelet secretory products. Am J Pathol (1991) 0.84

Epithelial ovarian cancer-induced angiogenic phenotype of human omental microvascular endothelial cells may occur independently of VEGF signaling. Transl Oncol (2013) 0.84

Comparative analysis of the early transcriptome of Brucella abortus--infected monocyte-derived macrophages from cattle naturally resistant or susceptible to brucellosis. Res Vet Sci (2010) 0.83

Thrombin-activated platelets promote leukotriene B4 synthesis in polymorphonuclear leucocytes stimulated by physiological agonists. Br J Pharmacol (1991) 0.83

An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action. Invest New Drugs (1997) 0.82

Immunomodulatory properties of platelet factor 4: prevention of concanavalin A suppressor-induction in vitro and augmentation of an antigen-specific delayed-type hypersensitivity response in vivo. Immunology (1990) 0.80

Distinct transcriptional signatures of bone marrow-derived C57BL/6 and DBA/2 dendritic leucocytes hosting live Leishmania amazonensis amastigotes. PLoS Negl Trop Dis (2012) 0.80

Platelet secretion of CXCL4 is Rac1-dependent and regulates neutrophil infiltration and tissue damage in septic lung damage. Br J Pharmacol (2015) 0.79

Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26. Front Immunol (2016) 0.79

Innate Immunity and Biomaterials at the Nexus: Friends or Foes. Biomed Res Int (2015) 0.78

Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease. Cardiovasc Diabetol (2003) 0.78

Platelet factor 4 is highly upregulated in dendritic cells after severe trauma. Mol Med (2009) 0.77

Bovine platelets retain functional activity in the presence of penicillin G. Can J Vet Res (1992) 0.75

Intercellular Interactions as Regulators of NETosis. Front Immunol (2016) 0.75

Differential effect of nicotinic acid derivatives on smooth muscle and endothelial cell proliferation. Basic Res Cardiol (1989) 0.75

Inhibition of human neutrophil receptor-mediated uptake of N-formyl-met-leu-phe by platelet factor 4 (59-70). Immunology (1985) 0.75

Saponins from Sanguisorba officinalis Improve Hematopoiesis by Promoting Survival through FAK and Erk1/2 Activation and Modulating Cytokine Production in Bone Marrow. Front Pharmacol (2017) 0.75

Articles cited by this

A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A (1974) 9.94

N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci U S A (1975) 9.24

Further studies on the chemotactic factor of complement and its formation in vivo. Immunology (1966) 7.59

Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1977) 5.87

Bacterial factors chemotactic for polymorphonuclear leukocytes. Am J Pathol (1968) 5.77

A plasmin-split fragment of C'3 as a new chemotactic factor. J Exp Med (1967) 4.94

A neutrophil chemotactic factor from human C'5. J Immunol (1969) 4.46

Amino acid sequence of human platelet factor 4. Proc Natl Acad Sci U S A (1977) 4.04

Leukotactic factor produced by sensitized lymphocytes. Science (1969) 3.95

Chemotactic activity of elastin-derived peptides. J Clin Invest (1980) 3.33

Collagen-and collagen peptide-induced chemotaxis of human blood monocytes. J Exp Med (1976) 3.17

Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid. J Clin Invest (1977) 3.10

Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes. Clin Exp Immunol (1970) 3.09

Platelet alpha-granule proteins: studies on release and subcellular localization. Blood (1979) 2.74

Alveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization. J Clin Invest (1980) 2.50

Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment. J Exp Med (1981) 2.10

Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization. J Clin Invest (1980) 2.04

Response of platelets to tissue injury. Biochem Pharmacol (1968) 2.01

Increased vascular permeability produced by human platelet granule cationic extract. J Clin Invest (1970) 1.98

Release of permeability factors from the blood platelet. Proc Soc Exp Biol Med (1966) 1.86

Selective neutrophil desensitization to chemotactic factors. J Cell Biol (1979) 1.77

Intravascular aggregation and pulmonary sequestration of platelets during IgE-induced systemic anaphylaxis in the rabbit: abrogation of lethal anaphylactic shock by platelet depletion. J Immunol (1977) 1.76

The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the 'reactive lysis' procedure. Immunology (1970) 1.73

The identification of fibrinopeptide B as a chemotactic agent derived from human fibrinogen. Br J Haematol (1974) 1.70

Platelet physiology and abnormalities of platelet function (second of two parts). N Engl J Med (1975) 1.69

Macrophage and neutrophil specific chemotactic factors in serum. Nature (1969) 1.58

Biochemical quantitation of the chemotactic factor inactivator activity in human serum. J Lab Clin Med (1979) 1.46

An improved method for the in vitro evaluation of monocyte leukotaxis. J Lab Clin Med (1977) 1.41

Urate crystal-induced chemotactic factor: isolation and partial characterization. J Clin Invest (1976) 1.34

Isolation by hydrophobic chromatography of the chemotactic factor inactivators from human serum. Clin Immunol Immunopathol (1979) 1.30

Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung. J Clin Invest (1978) 1.26

Characterization of human platelet vascular permeability-enhancing activity. J Clin Invest (1972) 1.20

Platelets, fibroblasts, and inflammation: tissue reactions to platelets injected subcutaneously. Am J Pathol (1980) 1.17

Subcellular localization of human platelet antiheparin proteins. Thromb Res (1979) 1.14

Polymorphonuclear leukocyte and monocyte chemoattractants produced by human fibroblasts. J Clin Invest (1979) 1.10

The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator. J Clin Invest (1973) 1.10

Generation of chemotactic activity for leukocytes by the action of thrombin on human fibrinogen. Nat New Biol (1973) 1.00

Human platelet factor 4: subcellular localization and characteristics of release from intact platelets. Thromb Res (1980) 0.98

Articles by these authors

MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell (1998) 9.70

Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature (1983) 8.60

Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science (1997) 8.19

Amino acid analysis by reverse-phase high-performance liquid chromatography: precolumn derivatization with phenylisothiocyanate. Anal Biochem (1984) 5.85

Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature (1999) 5.48

Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest (2000) 4.90

Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med (2001) 4.71

T-cell co-stimulation through B7RP-1 and ICOS. Nature (1999) 4.20

Amino acid sequence of human platelet factor 4. Proc Natl Acad Sci U S A (1977) 4.04

Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science (1987) 4.03

Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest (1982) 3.77

Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem (1993) 3.52

Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci U S A (2000) 3.37

Chemotactic activity of elastin-derived peptides. J Clin Invest (1980) 3.33

Human platelet-derived growth factor. Purification and resolution into two active protein fractions. J Biol Chem (1981) 3.21

Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol (1999) 3.21

A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. Science (1990) 2.80

The c-sis gene encodes a precursor of the B chain of platelet-derived growth factor. EMBO J (1984) 2.77

Amphiphilic secondary structure: design of peptide hormones. Science (1984) 2.71

Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem (1991) 2.71

Notch activity influences the alphabeta versus gammadelta T cell lineage decision. Cell (1997) 2.66

Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J Clin Invest (1990) 2.56

Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol (1989) 2.54

The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell (2000) 2.49

Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide. Proc Natl Acad Sci U S A (1977) 2.45

An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell (1996) 2.42

Expression of a platelet-derived growth factor-like protein in simian sarcoma virus transformed cells. Science (1983) 2.41

Transforming protein of simian sarcoma virus stimulates autocrine growth of SSV-transformed cells through PDGF cell-surface receptors. Cell (1984) 2.41

Platelet-derived growth factor stimulates tyrosine-specific protein kinase activity in Swiss mouse 3T3 cell membranes. Proc Natl Acad Sci U S A (1982) 2.39

Chemotactic activity of platelet alpha granule proteins for fibroblasts. J Cell Biol (1983) 2.28

Secondary structures of proteins and peptides in amphiphilic environments. (A review). Proc Natl Acad Sci U S A (1983) 2.26

Some kinetic properties of Bacillus subtilis glutamine synthetase. J Biol Chem (1970) 2.22

Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc Natl Acad Sci U S A (2000) 2.15

Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J Clin Invest (1994) 2.14

Bacillus subtilis glutamine synthetase. Purification and physical characterization. J Biol Chem (1970) 2.10

Induction of midbrain dopaminergic neurons by Sonic hedgehog. Neuron (1995) 2.08

Kinetics and mechanism of hemolysis induced by melittin and by a synthetic melittin analogue. Biophys J (1982) 2.03

Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol (1999) 2.02

Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science (1990) 2.00

Pseudomyxoma peritonei syndrome. Adv Surg (1996) 1.99

Elastase release from human alveolar macrophages: comparison between smokers and nonsmokers. Science (1977) 1.97

Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J Exp Med (1998) 1.96

The induction of pulmonary emphysema with human leukocyte elastase. Am Rev Respir Dis (1977) 1.95

Reconciliation of international administrative coding systems for comparison of colorectal surgery outcome. Colorectal Dis (2014) 1.91

Cation binding to the integrin CD11b I domain and activation model assessment. Structure (1998) 1.90

Proteolysis by neutrophils. Relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro. J Clin Invest (1982) 1.90

ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms. J Biol Chem (1994) 1.88

Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J Biol Chem (1996) 1.87

The interaction of hemoglobin with the cytoplasmic domain of band 3 of the human erythrocyte membrane. J Biol Chem (1984) 1.83

Amino acid sequence of phospholipase A2-alpha from the venom of Crotalus adamanteus. A new classification of phospholipases A2 based upon structural determinants. J Biol Chem (1977) 1.81

Electron microscopic alterations at the alveolar level in pulmonary edema. Circ Res (1967) 1.80

Platelet-derived growth factor. Specific binding to target cells. J Biol Chem (1982) 1.80

Transformation by v-sis occurs by an internal autoactivation mechanism. Science (1989) 1.79

Nucleotide sequence and expression of the capsid protein gene of feline calicivirus. J Virol (1991) 1.78

Characterization of the mannose/fucose receptor on human mononuclear phagocytes. J Reticuloendothel Soc (1982) 1.78

Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology (2000) 1.78

Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor. Proc Natl Acad Sci U S A (1989) 1.73

Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res (1995) 1.72

Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J Clin Invest (1986) 1.72

Role of platelet-derived growth factor in wound healing. J Cell Biochem (1991) 1.69

Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. Am J Respir Cell Mol Biol (1999) 1.69

Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution. Proc Natl Acad Sci U S A (1983) 1.67

Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. J Cell Biol (1984) 1.66

Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor. Proc Natl Acad Sci U S A (1985) 1.65

Platelet-derived growth factor elicits cyclic AMP accumulation in Swiss 3T3 cells: role of prostaglandin production. Cell (1983) 1.65

In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J Exp Med (1988) 1.64

The Hsp56 component of steroid receptor complexes binds to immobilized FK506 and shows homology to FKBP-12 and FKBP-13. J Biol Chem (1992) 1.63

Peptides with affinity for membranes. Annu Rev Biophys Biophys Chem (1987) 1.63

Elastin degradation by matrix metalloproteinases. Cleavage site specificity and mechanisms of elastolysis. J Biol Chem (1997) 1.62

Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. J Clin Invest (1985) 1.61

Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity. JAMA (1976) 1.60

A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base. J Biol Chem (1991) 1.59

Effects of cisapride on QT interval in children. J Pediatr (1998) 1.59

Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am J Pathol (2000) 1.59

Matrix metalloproteinases. Matrix degradation and more. Am J Respir Cell Mol Biol (1999) 1.57

Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. J Biol Chem (1992) 1.57

Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: relationship to drug resistance. Biochemistry (1995) 1.56

Purification and biochemical characterization of CP4 (SP-D), a collagenous surfactant-associated protein. Biochemistry (1989) 1.55

The atomic-resolution structure of human caspase-8, a key activator of apoptosis. Structure (1999) 1.54

The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats. J Biol Chem (1996) 1.53

Evolution of phosphofructokinase--gene duplication and creation of new effector sites. Nature (1984) 1.52

Molecular structure of pulmonary surfactant protein D (SP-D). J Biol Chem (1994) 1.51

Surfactant protein D is a divalent cation-dependent carbohydrate-binding protein. J Biol Chem (1990) 1.51

Design and characterization of peptides with amphiphilic beta-strand structures. J Cell Biochem (1985) 1.51

Drug- and toxin-induced rhabdomyolysis. Ann Emerg Med (1989) 1.51

The mechanism of activation of lecithin:cholesterol acyltransferase by apolipoprotein A-I and an amphiphilic peptide. J Biol Chem (1980) 1.50